Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-24T17:20:05.994Z Has data issue: false hasContentIssue false

A role for ipsilateral, selective neck dissection in carotid body tumours

Published online by Cambridge University Press:  08 March 2017

R P Morton*
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, Counties-Manukau District Health Board, Auckland, New Zealand
T Stewart
Affiliation:
Department of Otolaryngology-Head and Neck Surgery, Counties-Manukau District Health Board, Auckland, New Zealand
M S Dray
Affiliation:
Department of Pathology, Counties-Manukau District Health Board, Auckland, New Zealand
W Farmilo
Affiliation:
Department of Surgery, Counties-Manukau District Health Board, Auckland, New Zealand
*
Address for correspondence: Dr Randall P Morton, Department of Otolaryngology-Head and Neck Surgery, Counties-Manukau District Health Board, PO Box 98743, SAMC, Manukau City, Auckland, New Zealand. E-mail: [email protected]

Abstract

Introduction:

A reliable diagnosis of malignant carotid body tumour can only be made in the presence of metastatic disease, because the histological features of the primary tumour do not correlate with clinical behaviour.

Case report:

We report two cases of malignant carotid body tumour in which regional nodal biopsy at the time of excision of the primary tumour revealed unsuspected metastatic disease.

Discussion:

Reoperation in the neck for recurrent metastatic carotid body tumour is difficult and potentially hazardous. The presence of occult metastatic disease is easily identified if a selective – or sentinel – nodal dissection is performed routinely in cases of carotid body tumour excision. Such an approach adds very little morbidity, effort or time to the primary surgery, and is recommended. This view has been supported by some other authors but is generally overlooked in clinical practice.

Type
Clinical Records
Copyright
Copyright © JLO (1984) Limited 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Somasundar, P, Krouse, R, Hotsetter, R, Vaughan, R, Covey, T. Paragangliomas – a decade of clinical experience. J Surg Oncol 2000;74:286–903.0.CO;2-C>CrossRefGoogle ScholarPubMed
2 Knight, TT, Gonzalez, JA, Rary, JM, Rush, DS. Current concepts for the surgical management of carotid body tumour. Am J Surg 2006;191:104–10CrossRefGoogle Scholar
3 Lee, JH, Barich, F, Karnell, LH, Robinson, RA, Zhen, WK, Gantz, BJ. National cancer data base report on malignant paragangliomas of the head and neck. Cancer 2002;94:730–7CrossRefGoogle ScholarPubMed
4 Luna-Ortiz, K, Rascon-Ortiz, M, Villavicencio-Valencia, V, Granados-Garcia, M, Herrera-Gomez, A. Carotid body tumours: review of a 20-year experience. Oral Oncol 2005;41:5661CrossRefGoogle ScholarPubMed
5 Zbaren, P, Lehmann, W. Carotid paraganglioma with metastases. Laryngoscope 1985;95:450–4CrossRefGoogle ScholarPubMed
6 Gaylis, H, Mieny, CJ. The incidence of malignancy in carotid body tumours. Br J Surg 1977;64:885–9CrossRefGoogle ScholarPubMed
7 Ling, FJ, Weinrach, DM, Eskandari, MK. Carotid body tumour. A case report. Vasc Endovasc Surg 2004;38:185–8CrossRefGoogle ScholarPubMed
8 Cooper, RA, Slevin, NJ, Johnson, RJ, Evans, G. An unusual case of carotid body tumour. Clin Oncol 1998;10:62–4CrossRefGoogle ScholarPubMed
9 Liapis, CD, Evangelidakis, EL, Papavassiliou, VG, Kakisis, JD, Gougoulakis, AG, Polyzos, AK. Role of malignancy and preoperative embolization in the management of carotid body tumours. World J Surg 2000;24:1526–30CrossRefGoogle Scholar
10 Netterville, JL, Reilly, KM, Robertson, D, Reiber, ME, Armstrong, WB, Childs, P. Carotid body tumours: a review of 30 patients with 46 tumours. Laryngoscope 1995;105:115–26CrossRefGoogle Scholar
11 Pacheco-Ojeda, L. Malignant carotid body tumours: report of three cases. Ann Otol Rhinol Laryngol 2001;110:3640CrossRefGoogle ScholarPubMed